Eikon Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Eikon Therapeutics stock have an average target of 25.6, with a low estimate of 7.00 and a high estimate of 34. The average target predicts an increase of 85.51% from the current stock price of 13.80.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.00	$25.6	$29	$34
Change	-49.28%	+85.51%	+110.14%	+146.38%

Analyst Ratings

The average analyst rating for Eikon Therapeutics stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '26
Strong Buy	1
Buy	4
Hold	0
Sell	1
Strong Sell	0
Total	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Imogen Mansfield Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Mar 2, 2026
Brian Cheng JP Morgan	JP Morgan	Buy Initiates $29	Buy	Initiates	$29	+110.14%	Mar 2, 2026
Jason Zemansky B of A Securities	B of A Securities	Strong Buy Initiates $34	Strong Buy	Initiates	$34	+146.38%	Mar 2, 2026
Joseph Catanzaro Mizuho	Mizuho	Buy Initiates $26	Buy	Initiates	$26	+88.41%	Mar 2, 2026
Sean Laaman Morgan Stanley	Morgan Stanley	Buy Initiates $32	Buy	Initiates	$32	+131.88%	Mar 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.